Name | CCR1 antagonist 1 |
---|---|
Synonyms |
1-[4-(4-Chloro-3-methoxyphenyl)-1-piperazinyl]-2-[3-(1H-imidazol-2-yl)-1H-pyrazolo[3,4-b]pyridin-1-yl]ethanone
Ethanone, 1-[4-(4-chloro-3-methoxyphenyl)-1-piperazinyl]-2-[3-(1H-imidazol-2-yl)-1H-pyrazolo[3,4-b]pyridin-1-yl]- 22PQS5K5TY CCX-354 |
Description | CCR1 antagonist 1 is an antagonist of CCR1, with anti-inflammatory activity. |
---|---|
Related Catalog | |
Target |
CCR1 |
In Vitro | CCR1 antagonist 1 shows potent activities in the chemotaxis assay, with IC50 < 100 nM[1]. |
In Vivo | In vivo, CCR1 antagonist 1 has in vivo anti-inflammatory activity and has superior pharmacokinetic properties[1]. |
References |
[1]. Compounds for the treatment of osteoporosis and cancers. US 20100113472 A1 |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 778.4±60.0 °C at 760 mmHg |
Molecular Formula | C22H22ClN7O2 |
Molecular Weight | 451.909 |
Flash Point | 424.6±32.9 °C |
Exact Mass | 451.152344 |
LogP | 1.24 |
Vapour Pressure | 0.0±2.7 mmHg at 25°C |
Index of Refraction | 1.724 |